Convenors: Bastian Rake, Maureen McKelvey and Magnus Gulbrandsen.
Session type: Full paper session.
The global COVID-19 pandemic and the need for rapid responses to it challenge existing ways of innovating and have been a trigger event for rethinking many routines and processes in medical innovation (Chesbrough, 2020; George et al., 2020). Therefore, there is a need to carefully reassess our knowledge about medical innovation specifically in relation to the processes associated with it in times of crisis. As there are considerable health challenges that may cause another crisis (Pereira et al., 2020), avoiding potentially negative medium- and long-term consequences for the organization of (medical) innovation as well as for innovative output becomes a key question (Frey, 2020). Another key question is whether the extraordinary COVID-19 efforts can be transferred to more normal situations. Studying medical crisis thus offers the opportunity to focus upon innovation as responses to that specific event, as well as the effect of a crisis on other desirable outcomes, processes and impacts on healthcare and society.
We invite submissions studying the topic of “Rethinking Medical Innovation in Times of Crisis” in a variety of contexts and encourage submissions that go beyond immediate crisis response to study the medium- and long-term impact of a crisis. To reach this goal, we have developed three broader themes of primary interest for this track. Submissions must be related to one or more of these themes, but that we accept papers that offer clearly complementary perspectives within a theme.
Theme 1: The Changing Organization of Medical Innovation and R&D
Theme 2: Medical Innovation and Delivery of Care Around Hospitals and Patients
Theme 3: Crisis Response in Companies
The organizers are negotiating a special issue in an appropriate journal and invite submissions of the best contributions of this track. Authors should be aware that contributions submitted to the special issue undergo the normal peer review process. Submissions for the special issue are expected to be due shortly after the conference. Therefore, the expectation is that authors submit full papers to this track.
Sessions of this track will involve sets of thematically grouped papers. Each paper will be presented orally. These presentations are followed by commentaries presented by discussants who have been assigned to each paper in advance. Thereafter, the audience is asked to provide questions and comments.
Chesbrough, H., 2020. To recover faster from Covid-19, open up: Managerial implications from an open innovation perspective. Industrial Marketing Management 88, 410–413. doi:10.1016/j.indmarman.2020.04.010.
Frey, C.B., 2020. The Great Innovation Deceleration. MIT Sloan Management Review 61 (4), 1–3.
George, G., Lakhani, K.R., Puranam, P., 2020. What has changed? The Impact of Covid Pandemic on the Technology and Innovation Management Research Agenda. Journal of Management Studies n/a (n/a). doi:10.1111/joms.12634.
Pereira, V., Temouri, Y., Patnaik, S., Mellahi, K., 2020. Managing and preparing for emerging infectious diseases: Avoiding a catastrophe. Academy of Management Perspectives. doi:10.5465/amp.2019.0023.